Search Results
Search for other papers by Qi Zhang in
Google Scholar
PubMed
Search for other papers by Hongshan Wang in
Google Scholar
PubMed
Search for other papers by Yanhong Xie in
Google Scholar
PubMed
Search for other papers by Suming Huang in
Google Scholar
PubMed
Search for other papers by Ke Chen in
Google Scholar
PubMed
Search for other papers by Botian Ye in
Google Scholar
PubMed
Search for other papers by Yupeng Yang in
Google Scholar
PubMed
Search for other papers by Jie Sun in
Google Scholar
PubMed
Search for other papers by Hongyong He in
Google Scholar
PubMed
Search for other papers by Fenglin Liu in
Google Scholar
PubMed
Search for other papers by Zhenbin Shen in
Google Scholar
PubMed
Search for other papers by Weidong Chen in
Google Scholar
PubMed
Search for other papers by Kuntang Shen in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Yihong Sun in
Google Scholar
PubMed
of gastric neuroendocrine neoplasms (gNENs) ( 12 ). However, Coriat et al. ( 13 ) found that the gastric-originated neoplasms accounted for 8–24% in G3 NET and 7–8% in NEC in several major studies on GEP-NENs. The investigation on gastric high-grade
Search for other papers by Klaus W Fagerstedt in
Google Scholar
PubMed
HUH Diagnostic Center and Helsinki University Hospital, Helsinki, Finland
Search for other papers by Tom Böhling in
Google Scholar
PubMed
Search for other papers by Harri Sihto in
Google Scholar
PubMed
Search for other papers by Tarja Salonen in
Google Scholar
PubMed
Search for other papers by Fang Zhao in
Google Scholar
PubMed
HUH Diagnostic Center and Helsinki University Hospital, Helsinki, Finland
Search for other papers by Mia Kero in
Google Scholar
PubMed
Search for other papers by Leif C Andersson in
Google Scholar
PubMed
HUH Diagnostic Center and Helsinki University Hospital, Helsinki, Finland
Search for other papers by Johanna Arola in
Google Scholar
PubMed
). Tumor cell lines offer versatile tools for studying the molecular biology of neoplasms. Here we describe the establishment and characterization of a spontaneously transformed cell line from a gastric MINEN, composed of high-grade neuroendocrine carcinoma
Search for other papers by Peiwen Wu in
Google Scholar
PubMed
Search for other papers by Dongjie He in
Google Scholar
PubMed
Search for other papers by Hao Chang in
Google Scholar
PubMed
Search for other papers by Xiaozhi Zhang in
Google Scholar
PubMed
increased significantly ( Fig. 2B ). Figure 2 Incidence of neuroendocrine tumors from 2000 to 2018. (A) All neuroendocrine tumors and all malignant neoplasms, (B) by sex and race, (C) by stage and grade, (D) by site. NETs, neuroendocrine tumors
Search for other papers by Matteo Scopel in
Google Scholar
PubMed
Search for other papers by Eugenio De Carlo in
Google Scholar
PubMed
Search for other papers by Francesca Bergamo in
Google Scholar
PubMed
Search for other papers by Sabina Murgioni in
Google Scholar
PubMed
Search for other papers by Riccardo Carandina in
Google Scholar
PubMed
Search for other papers by Anna Rita Cervino in
Google Scholar
PubMed
Search for other papers by Marta Burei in
Google Scholar
PubMed
Search for other papers by Federica Vianello in
Google Scholar
PubMed
Search for other papers by Vittorina Zagonel in
Google Scholar
PubMed
Search for other papers by Matteo Fassan in
Google Scholar
PubMed
Search for other papers by Roberto Vettor in
Google Scholar
PubMed
(92% of total) are invariably low-grade NETs (grading equal to or lower than G2 or typical/atypical carcinoid), on the other hand, in the synchronous group, the low-grade tumors represent only 70% and there is a 13% of high-grade neuroendocrine
Search for other papers by Thomas Couronne in
Google Scholar
PubMed
Search for other papers by Paul Girot in
Google Scholar
PubMed
Search for other papers by Julien Hadoux in
Google Scholar
PubMed
Search for other papers by Thierry Lecomte in
Google Scholar
PubMed
Search for other papers by Alice Durand in
Google Scholar
PubMed
Search for other papers by Caroline Fine in
Google Scholar
PubMed
Search for other papers by Katia Vandevoorde in
Google Scholar
PubMed
Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed
Search for other papers by Thomas Walter in
Google Scholar
PubMed
. Gastroenteropancreatic high-grade neuroendocrine carcinoma . Cancer 2014 120 2814 – 2823 . ( https://doi.org/10.1002/cncr.28721 ) 5 Garcia-Carbonero R Sorbye H Baudin E Raymond E Wiedenmann B Niederle B Sedlackova E Toumpanakis C Anlauf M
Search for other papers by Ashley K Clift in
Google Scholar
PubMed
Search for other papers by Omar Faiz in
Google Scholar
PubMed
Search for other papers by Robert Goldin in
Google Scholar
PubMed
Search for other papers by John Martin in
Google Scholar
PubMed
Search for other papers by Harpreet Wasan in
Google Scholar
PubMed
Search for other papers by Marc-Olaf Liedke in
Google Scholar
PubMed
Search for other papers by Erik Schloericke in
Google Scholar
PubMed
Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland
Search for other papers by Anna Malczewska in
Google Scholar
PubMed
Search for other papers by Guido Rindi in
Google Scholar
PubMed
Search for other papers by Mark Kidd in
Google Scholar
PubMed
Search for other papers by Irvin M Modlin in
Google Scholar
PubMed
Search for other papers by Andrea Frilling in
Google Scholar
PubMed
stage have been developed for SB NET, namely the World Health Organisation (WHO)/European Neuroendocrine Tumor Society (ENETS) staging and grading system ( 15 ) and the American Joint Committee on Cancer/Union Internationale Contre le Cancer (AJCC
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by Mark J C van Treijen in
Google Scholar
PubMed
Department of Clinical Chemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Catharina M Korse in
Google Scholar
PubMed
Department of Gastroenterology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Wieke H Verbeek in
Google Scholar
PubMed
Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Search for other papers by Margot E T Tesselaar in
Google Scholar
PubMed
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Search for other papers by Gerlof D Valk in
Google Scholar
PubMed
for gastric neuroendocrine neoplasms . Journal of Cancer 2019 10 5944 – 5954 . ( https://doi.org/10.7150/jca.35785 ) 8 Modlin IM Gustafsson BI Pavel M Svejda B Lawrence B Kidd M . A nomogram to assess small-intestinal neuroendocrine
Department of Pancreatic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
Search for other papers by Wentao Zhou in
Google Scholar
PubMed
Search for other papers by Tiantao Kuang in
Google Scholar
PubMed
Search for other papers by Xu Han in
Google Scholar
PubMed
Search for other papers by Wenqi Chen in
Google Scholar
PubMed
Search for other papers by Xuefeng Xu in
Google Scholar
PubMed
Search for other papers by Wenhui Lou in
Google Scholar
PubMed
Search for other papers by Dansong Wang in
Google Scholar
PubMed
Introduction Pancreatic neuroendocrine neoplasm (pNEN) is a rare malignancy arising from pancreatic islet cells and accounts for 1–2% of all pancreatic tumors ( 1 ). However, with the popularization of abdominal imaging and the promotion of
Search for other papers by Carole Morin in
Google Scholar
PubMed
Search for other papers by Keo-Morakort Benedetto in
Google Scholar
PubMed
Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
Search for other papers by Agathe Deville in
Google Scholar
PubMed
University of Lyon, Université Lyon 1, France
Search for other papers by Laurent Milot in
Google Scholar
PubMed
Search for other papers by Aurélie Theillaumas in
Google Scholar
PubMed
University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Institut de Pathologie Est, Bron Cedex, France
Search for other papers by Valérie Hervieu in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Edouard Herriot, Gastroentérologie, Lyon Cedex 03, France
Search for other papers by Mathieu Pioche in
Google Scholar
PubMed
University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France
Search for other papers by Gilles Poncet in
Google Scholar
PubMed
Search for other papers by Julien Forestier in
Google Scholar
PubMed
Search for other papers by Laurent François in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Louis Pradel, Endocrinologie, Bron Cedex, France
Search for other papers by Francoise Borson-Chazot in
Google Scholar
PubMed
Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France
Search for other papers by Mustapha Adham in
Google Scholar
PubMed
Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed
Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
University of Lyon, Université Lyon 1, France
Search for other papers by Thomas Walter in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasm (NEN) is a rare disease, though its incidence is rising ( 1 , 2 ). NENs are heterogeneous diseases regarding the number of primary origins, clinical presentation, staging, grading, and prognosis. Their
Search for other papers by Linfei Yang in
Google Scholar
PubMed
Search for other papers by Xiao Yu in
Google Scholar
PubMed
European Pancreas Center, Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany
Search for other papers by Yongchao Yang in
Google Scholar
PubMed
test was used for statistics analysis. ★ P < 0.001 vs NC. ATX, autotaxin; NC, normal control; pNEN, pancreatic neuroendocrine neoplasms. ATX expression levels are significantly correlated with tumour grade, lymph node metastasis and TNM